These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10757070)

  • 21. [Immunoreactivity of nuclear protein p53 in differentiated thyroid cancers].
    Dedov II; Gerasimov GA; Bronshteĭn MI; Aleksandrova GF; Troshina EA; Figge J
    Biull Eksp Biol Med; 1996 Dec; 122(12):645-7. PubMed ID: 9280463
    [No Abstract]   [Full Text] [Related]  

  • 22. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu X; An Q; Zhang J; Tang P; Cheng S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
    Xu XF; Gao YN; Cheng SJ
    Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of allelic loss on 1q, 4p, 7q, 9p, 9q, and 16q with postoperative death in papillary thyroid carcinoma.
    Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
    Clin Cancer Res; 2000 May; 6(5):1819-25. PubMed ID: 10815903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.
    Paterson RF; Ulbright TM; MacLennan GT; Zhang S; Pan CX; Sweeney CJ; Moore CR; Foster RS; Koch MO; Eble JN; Cheng L
    Cancer; 2003 Nov; 98(9):1830-6. PubMed ID: 14584063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional loss of tumor suppressor genes detected by loss of heterozygosity, but not driver mutations, predicts aggressive lymph node status in papillary thyroid carcinoma.
    Finkelstein S; Timmaraju VA; Samankan S; O'Malley Q; Kapustin D; Spaulding S; Xing M; Matloob A; Beute J; Seo G; Saturno M; Greenberg L; Wein L; Gonzalez-Velazquez C; Doyle S; Levine J; Urken M; Brandwein-Weber M
    Pathol Res Pract; 2023 Nov; 251():154842. PubMed ID: 37890270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.
    Wreesmann VB; Ghossein RA; Hezel M; Banerjee D; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B
    Genes Chromosomes Cancer; 2004 Aug; 40(4):355-64. PubMed ID: 15188460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The null genotype of glutathione s-transferase M1 and T1 locus increases the risk for thyroid cancer.
    Morari EC; Leite JL; Granja F; da Assumpção LV; Ward LS
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1485-8. PubMed ID: 12433731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PCR artifacts in LOH and MSI analysis of microdissected tumor cells.
    Sieben NL; ter Haar NT; Cornelisse CJ; Fleuren GJ; Cleton-Jansen AM
    Hum Pathol; 2000 Nov; 31(11):1414-9. PubMed ID: 11112218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
    Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
    Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic significance of loss of heterozygosity on chromosome 1 in cervical cancer.
    Cheung TH; Lo KW; Yim SF; Poon CS; Cheung AY; Chung TK; Wong YF
    Gynecol Oncol; 2005 Feb; 96(2):510-5. PubMed ID: 15661244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder.
    Cheng L; MacLennan GT; Zhang S; Wang M; Pan CX; Koch MO
    Cancer; 2004 Jul; 101(1):183-8. PubMed ID: 15222005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions.
    Albores-Saavedra J; Hernandez M; Sanchez-Sosa S; Simpson K; Angeles A; Henson DE
    Am J Surg Pathol; 2007 May; 31(5):729-36. PubMed ID: 17460457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
    Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
    Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Loss of heterozygosity in the 9p21 region as an inactivation mechanism of the p16 suppressor gene].
    Maestro de las Casas ML; Sanz-Casla MT; del Barco V; Moreno J; Zanna I; Redondo E; Fernández C; Izquierdo L; Resel Estévez L
    Arch Esp Urol; 2000 Sep; 53(7):603-9. PubMed ID: 11037653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular evidence supporting the neoplastic nature of odontogenic keratocyst: a laser capture microdissection study of 15 cases.
    Henley J; Summerlin DJ; Tomich C; Zhang S; Cheng L
    Histopathology; 2005 Dec; 47(6):582-6. PubMed ID: 16324195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative genomic instabilities of thyroid and colon cancers.
    Stoler DL; Nowak NJ; Matsui S; Wiseman SM; Chen N; Dutt SS; Bartos JD; Loree TR; Rigual NR; Hicks WL; Sait SN; Anderson GR
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):457-63. PubMed ID: 17515504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.